In 1973, the UK based multinational pharmaceutical company, ICI plc, established a subsidiary in Dhaka, known as ICI Bangladesh Manufacturers

Limited. In 1992, ICI plc divested its share to local management, and the company was renamed Advanced Chemical Industries (ACI) Limited. ACI formulates and markets a comprehensive range of more than 387 products covering all major therapeutic areas, which come in tablet, capsule, powder, liquid, cream, ointment, gel ,ophthalmic and injection forms. ACI also markets world-renowned branded pharmaceutical products like Arimidex, Casodex, Zoladex, Atarax etc. from world-class multinational companies like ASTRAZENECA, UK and UCB, BELGIUM in Bangladesh. ACI is actively engaged in introducing newer molecules and Novel Drug Delivery Systems (NDDS) to meet the needs of the future. ACI introduced the concept of quality management system by being the first company in Bangladesh to achieve ISO 9001 certification in 1995 and follows the policy of continuous improvement in all its operations. Aligned with the concept that a pharmaceutical must ensure effective management of environment, ACI complies with standard environment management policy, thus adorned with EMS 14001 in 2000. ACI maintains a congenial and supportive relationship with the healthcare community of Bangladesh, with the belief that business excellence can only be achieved through pursuit of quality by understanding, accepting, meeting and exceeding customer expectations. The management of ACI, a competent team of professionals, thus operates with a progressive attitude to provide effective solutions to satisfy the customers needs, through its products and services of uncompromising quality

Location and area The pharmaceutical manufacturing plant is located at Narayanganj, by the bank of river Shitolokkhya. It encompasses a land area of 11.5 acres with 85,000 square feet covered area. 235 skilled persons are involved in the plant to produce world class quality products. Facilities The plant is well designed and well equipped with all latest facilities and state-of-the-art technologies. The responsible team of plant workers, supervisors, officers and managers strictly follow cGMP recommended by WHO and In-process Quality control methodology for production and meets all national regulatory requirements. Product Development This creative team of professionals is engaged in developing new formulations and dosage forms with competitive advantages and strong product differentiation. Production This highly skilled team is dedicated in producing products with consistent quality under

clearly defined Standard Operating Procedures (SOP) in compliance with the procedures and instructions of ISO 9001 quality system. Quality Assurance This dedicated team plays the vigilant role of controlling, ensuring and maintaining the consistent quality of products for which ACI is so well recognized.

Market Domestic market Being a developing country, the pharmaceutical market and at the same time, the pharmaceutical industry of Bangladesh is growing. In this growing market, ACI has been able to maintain its growth through its innovative marketing strategies. In Bangladesh, ACI introduced the concept of quality management system by being the first company to achieve ISO 9001 certification that reflects its commitment to quality in every aspect of business. ACI covers the health care community of whole Bangladesh based in both urban and rural markets, through its 18 strategically located depots. International market To fuel the continuous growth of ACI, the company has started exploring international markets. The quality of ACI products, strengthened by its ISO 9001 certification, has brought immediate success in Sri Lanka, Yemen, Myanmar and Vietnam.

International Operation After assuring its credentials in the pharmaceutical industry of the country, ACI Limited began spreading its wings toward greater interaction, integration and interdependence among people and organization across borders with trust on becoming a global player in the international market. ACI Limited started exporting medicine in 1999. The quality of ACI products, strengthened by its ISO 9001 certification, has brought immediate success in Sri Lanka, Myanmar, Vietnam and Yemen.

International Operation After assuring its credentials in the pharmaceutical industry of the country, ACI Limited began spreading its wings toward greater interaction, integration and interdependence among people and organization across borders with trust on becoming a global player in the

international market. ACI Limited started exporting medicine in 1999. The quality of ACI products, strengthened by its ISO 9001 certification, has brought immediate success in Sri Lanka, Myanmar, Vietnam and Yemen.

International Markets
Present Markets
Sri Lanka Myanmar Vietnam Yemen Somalia Afghanistan Guatemala Hong Kong Bhutan Kenya Belize Nepal Kenya Sudan Cambodia Macau Philippines Ivory Cost Mongolia

Markets Under-Development

Highlights:
Exports pharmaceutical finished products since 1999 Offers 224 products in 481 dosage forms covering almost all the therapeutic classes Offers world class products at an affordable price Own R & D facilities to develop both formulations and ready to fill bulk pellets Offers facilities for contract manufacturing Offers assistance in product promotion and training for overseas market.

Future Focus:
Work is in progress to explore more markets of Asia, Africa and Central America

ACI Limited will introduce Dry Powder Inhalers (DPI), Human Insulins and Hormones in the year 2012 ACI Limited has commissioned a dedicated ophthalmic preparation facility and will introduce more ophthalmic products soon Projects of new manufacturing units for regulated markets (including USA, EU etc) is going on and will commence in Q1 2014.